One Platform, Every Ailment: Hinge Health's Gamble
Hinge Health's stock has surged in 2026 on strong Q2 earnings and expansion into migraine and GI care, but its rich valuation leaves little room for execution missteps.
Read the full story at MarketBeat News Feed →